Observational Study on Youth-Onset Type 2 Diabetes and Heart Health

This observational study, called "Young at Heart," aims to understand how youth-onset type 2 diabetes affects heart and blood vessel (vascular) health in young people. Researchers want to identify factors that might lead to heart disease in individuals aged 12 to 25. They will compare young people with type 2 diabetes to those who are overweight but don't have diabetes, and to healthy individuals of the same age. The study will look at measures like pulse wave velocity (how fast blood travels through arteries) and augmentation index (a measure of arterial stiffness) at the beginning of the study and again after 5 years. Biological parents of participants will also be included for a single visit to help understand family factors.

Study design
This is an observational study with a planned enrollment of 930 participants. It compares three groups of young people: those with type 2 diabetes, those who are overweight, and healthy individuals.
What's involved
Young participants will visit the NIH clinic once a year for up to 25 years, with each visit lasting 4 days. Biological parents will have a single-day visit.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for at least 5 years, with some measures taken at baseline and again at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06730113

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Recruiting
Not specifiedAges 12–25Observational
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
~930 participants
Updated 2026-08-05 on ClinicalTrials.gov

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pulse wave velocity (PWV)
Measured over Baseline
+3 more outcomes measured
Obesity
Type 2 Diabetes
2 sites across 2 states
District of Columbia1
Maryland1
  • Stephanie T Chung, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Opens a ready-to-send draft in your own email app — review before sending.

  • Pulse wave velocity (PWV)Baseline

    Carotid-femoral pulse wave velocity (m/s) measured with SphygmaCor, higher numbers indicated greater arterial stiffness

  • Augmentation index (Aix)Baseline

    Augmentation index (%) measured with SphygmaCor, higher numbers indicated greater arterial stiffness.

  • Pulse wave velocity (PWV)5 Years

    Carotid-femoral pulse wave velocity (m/s) measured with SphygmaCor

  • Augmentation index (Aix)5 Years

    Augmentation index (%) measured with SphygmaCor